vs
BillionToOne, Inc.（BLLN）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是BillionToOne, Inc.的1.4倍（$117.7M vs $83.5M），BillionToOne, Inc.净利率更高（6.8% vs -1.5%，领先8.3%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $6.5M）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
BLLN vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.4倍
$83.5M
净利率更高
BLLN
高出8.3%
-1.5%
自由现金流更多
RHLD
多$182.8M
$6.5M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $117.7M |
| 净利润 | $5.7M | $-1.7M |
| 毛利率 | 69.9% | 55.7% |
| 营业利润率 | 11.5% | 30.2% |
| 净利率 | 6.8% | -1.5% |
| 营收同比 | 117.4% | — |
| 净利润同比 | 138.3% | — |
| 每股收益（稀释后） | $0.10 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNRHLD
| Q4 25 | — | $117.7M | ||
| Q3 25 | $83.5M | $120.9M | ||
| Q2 25 | — | $119.6M | ||
| Q1 25 | — | $103.9M | ||
| Q3 24 | $38.4M | — |
净利润BLLNRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $5.7M | $-231.0K | ||
| Q2 25 | — | $-611.0K | ||
| Q1 25 | — | $-3.4M | ||
| Q3 24 | $-14.9M | — |
毛利率BLLNRHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | 69.9% | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q3 24 | 52.6% | — |
营业利润率BLLNRHLD
| Q4 25 | — | 30.2% | ||
| Q3 25 | 11.5% | 34.3% | ||
| Q2 25 | — | 34.0% | ||
| Q1 25 | — | 24.7% | ||
| Q3 24 | -32.9% | — |
净利率BLLNRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | 6.8% | -0.2% | ||
| Q2 25 | — | -0.5% | ||
| Q1 25 | — | -3.2% | ||
| Q3 24 | -38.8% | — |
每股收益（稀释后）BLLNRHLD
| Q4 25 | — | $-0.20 | ||
| Q3 25 | $0.10 | $-0.03 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.39 | ||
| Q3 24 | $-1.47 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | $205.5M |
| 总债务越低越好 | $55.0M | $169.8M |
| 股东权益账面价值 | $-239.5M | $6.5M |
| 总资产 | $327.5M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资BLLNRHLD
| Q4 25 | — | $205.5M | ||
| Q3 25 | $195.2M | $148.0M | ||
| Q2 25 | — | $99.9M | ||
| Q1 25 | — | $71.0M | ||
| Q3 24 | — | — |
总债务BLLNRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | $55.0M | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q3 24 | — | — |
股东权益BLLNRHLD
| Q4 25 | — | $6.5M | ||
| Q3 25 | $-239.5M | $10.8M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $8.9M | ||
| Q3 24 | $-242.9M | — |
总资产BLLNRHLD
| Q4 25 | — | $333.4M | ||
| Q3 25 | $327.5M | $293.2M | ||
| Q2 25 | — | $253.3M | ||
| Q1 25 | — | $214.3M | ||
| Q3 24 | — | — |
负债/权益比BLLNRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q3 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $189.2M |
| 自由现金流率自由现金流/营收 | 7.7% | 160.8% |
| 资本支出强度资本支出/营收 | 8.8% | 5.8% |
| 现金转化率经营现金流/净利润 | 2.42× | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流BLLNRHLD
| Q4 25 | — | $196.1M | ||
| Q3 25 | $13.8M | $59.6M | ||
| Q2 25 | — | $48.9M | ||
| Q1 25 | — | $18.4M | ||
| Q3 24 | — | — |
自由现金流BLLNRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | $6.5M | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q3 24 | — | — |
自由现金流率BLLNRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | 7.7% | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q3 24 | — | — |
资本支出强度BLLNRHLD
| Q4 25 | — | 5.8% | ||
| Q3 25 | 8.8% | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.6% | ||
| Q3 24 | — | — |
现金转化率BLLNRHLD
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
RHLD
暂无分部数据
